Based in the biotech hub of Martinsried just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank in 2009 to develop messenger RNA as a new drug modality. The company’s focus is to develop products based on its’ proprietary SNIM®RNA technology to treat patients with respiratory disorders. Ethris has developed a pipeline of Transcript Therapies for rare and genetic respiratory diseas...
Based in the biotech hub of Martinsried just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank in 2009 to develop messenger RNA as a new drug modality. The company’s focus is to develop products based on its’ proprietary SNIM®RNA technology to treat patients with respiratory disorders. Ethris has developed a pipeline of Transcript Therapies for rare and genetic respiratory diseases, and is working with partners to advance programs for other respiratory diseases and for non-respiratory conditions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.